Fortrea Holdings Inc. (FTRE) stock
Close on Nov 12, 2026Market cap $1.94BP/E –Yield –
Fortrea Holdings Inc. saw revenue fall 3.4% to $2.67B over the twelve months to Sep 30, 2026. Free cash flow was $169.00M. At the latest close the market valued the company at $1.94B.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026
Valuation
- Market cap
- $1.94B
- P/E ratio
- –
- Price to sales
- 0.73
- Price to book
- 3.64
- Dividend yield
- –
- Free cash flow yield
- 8.73%
Fundamentals
- Revenue
- $2.67B
- Net income
- -$68.70M
- EPS, diluted
- -$10.81
- Free cash flow
- $169.00M
- Book value per share
- $5.26
- Diluted shares
- 101M
Trading
- Next earnings
- Feb 25, 2027 (estimated, before the open)
- Previous close
- $20.38
- Open
- $19.96
- Day's range
- $18.97 – $20.29
- Volume
- 1,594,385
- Average volume (20 days)
- 2,037,378
- Index membership
- S&P SmallCap 600 (since Aug 2023), Russell 2000 (since Jun 2025), Russell 3000 (since Aug 2023)
- Beta (5 years)
- 1.47
- 52-week range
- $8.55 – $26.16
- RSI (14 days)
- 42.6
- Volatility (1 year)
- 68.1%
- Relative volume
- 0.99×
- WACC
- 9.8%
Index membership is inferred from the holdings of funds that track each index (SPSM, IJR, IWM, IWV), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.
Market cap history
Month-end market cap since 2023, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | FTRE | S&P 500 | Difference | FTRE per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -4.5% | -2.7% | −1.8 pts | ||
| 3 months | +9.4% | -1.7% | +11.2 pts | ||
| Year to date | +16.3% | +11.9% | +4.4 pts | ||
| 1 year | +76.9% | +12.0% | +64.9 pts | ||
| 3 years | -28.9% | +78.2% | −107.1 pts | -10.7% | +21.2% |
Six years at a glance
Fiscal years 2020 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Fortrea filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Update
- Results
- Results
- Results
About Fortrea
Services-Medical Laboratories
Fortrea Holdings Inc. is a global contract research organization that delivers biopharmaceutical product and medical device development services. The company provides clinical pharmacology, phase I through IV clinical trial management, and specialized consulting services across more than twenty therapeutic areas, including oncology, central nervous system disorders, and metabolic diseases. Fortrea manages its business within a single reporting segment, Clinical Services, and serves pharmaceutical, biotechnology, and medical device companies ranging from small and emerging biotechs to large global pharmaceutical firms.
Company profile, executives and historyFortrea stock: common questions
What is Fortrea's stock price?
FTRE closed at $20.06 on Nov 12, 2026, down 1.57% on the day. Over the past 52 weeks it traded between $8.55 and $26.16.
What is Fortrea's market cap?
Fortrea was worth $1.94B at the close on Nov 12, 2026: the share price times the diluted shares outstanding.
What is FTRE's P/E ratio?
Fortrea lost money over fiscal 2025 (diluted EPS -$10.81), so it has no meaningful P/E ratio.
How much revenue does Fortrea make?
Fortrea reported revenue of $2.67B for the twelve months to Sep 30, 2026, down 3.4% from a year earlier.
Does Fortrea pay a dividend?
No. Fortrea has not paid a cash dividend over the last twelve months.
When does Fortrea report earnings next?
Fortrea is expected to report Q4 FY2026 results on Feb 25, 2027, before the open. The date is estimated from its past reporting pattern until the company confirms it.
How has FTRE stock performed over the past year?
Including dividends, FTRE returned +76.9% over the past year, against +12.0% for the S&P 500.
How many FTRE shares are sold short?
9M shares were sold short at the latest FINRA report, 9.25% of the float, or 3.7 days of average trading volume.
Who are Fortrea's competitors?
Companies most similar to Fortrea by business, industry and size include NTRA, LH, CAI, RDNT, GH.
See a number that looks wrong?